SkinMedica(R) Empowers Clear Skin Confidence with a New, Modern Approach to Acne PR Newswire
Market data is delayed by at least 15 minutes.
    Latest Story
    SkinMedica(R) Empowers Clear Skin Confidence with a New, Modern Approach to Acne
     PR Newswire

    -- From the makers of BOTOX(R) Cosmetic, two new SkinMedica(R)acne products help address skin blemishes and can be combined with in-office DiamondGlow(R)

    Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the launch of two new products from SkinMedica(R) by the makers of BOTOX(R) Cosmetic. The SkinMedica(R) Acne Clarifying Treatment and SkinMedica(R) Pore Purifying Gel Cleanser are breakthroughs in skincare, providing effective and balanced care for people with acne-prone skin. The two products, along with the SkinMedica(R) Pore Purifying Pro-Infusion Serum, used in-office with DiamondGlow(R), complete the protocol, providing acne sufferers a continuum of products to help address their skin concerns.

    Full Story →

    Headline News
    SHAREHOLDER ALERT: Weiss Law Investigates Landos Biopharma, Inc.
    4:01p ET April 4 '24 ACCESSWIRE
    AbbVie to Host First-Quarter 2024 Earnings Conference Call
    8:00a ET April 4 '24 PR Newswire
    Allergan Aesthetics Announces the Return of CoolMonth with CoolSculpting(R)
    8:30a ET April 3 '24 PR Newswire
    More News →
    Day  1.85%Week  2.61%Month  3.65%More Charting →
    May 3 '24. Markets Closed.
    Last $163.79
    Day change   1.85%$2.98
    Open $161.16
    Gap at open $0.35
    Previous close $160.81
    Trading volume 5,850,102
    10 Day avg vol. 5,860,922
    Shares out. 1.8Bil
    Market cap. $290.0Bil
    Trading activity Below Avg.
    Previous data from yesterday, May 2 '24.

    Historical Price Performance
    3 month   4.36% 
    6 month   15.22% 
    1 year   10.65% 
    2 year   7.17% 

    Earnings
    Previous 12m $2.72
    Next 12m Estimate $11.24
    P/E ratio 60.2x
    Revenue 54,318Mil

    Market data provided by News provided by